Reversal of pancytopenia following kidney transplantation in a patient of primary hyperoxaluria with bone marrow involvement
- PMID: 15663648
- DOI: 10.1111/j.1440-1797.2004.00317.x
Reversal of pancytopenia following kidney transplantation in a patient of primary hyperoxaluria with bone marrow involvement
Abstract
Combined liver and kidney transplantation is the ideal treatment for patients with end-stage renal failure secondary to primary hyperoxaluria and systemic oxalosis, with a functioning liver providing replacement of the deficient enzyme and a functioning kidney providing the route of excretion for the oxalate crystals. Pancytopenia from bone marrow infiltration of oxalate crystals is a rare complication of primary hyperoxaluria, and its reversal following transplant has not been described. We report the first case of pancytopenia from marrow infiltration by oxalate crystals reversing following a successful kidney transplant alone. Although kidney alone transplants do not provide the best chance of survival or quality of life as compared to a combined kidney and liver transplant, a well functioning kidney transplant is able to take care of the systemic oxalate load and ameliorate, at least for a period of time, the systemic complications of oxalosis.
Similar articles
-
Recurrence of oxalate deposition in a renal transplant during ciclosporin A therapy.Child Nephrol Urol. 1988-1989;9(1-2):90-2. Child Nephrol Urol. 1988. PMID: 3075154
-
Pancytopenia due to massive bone marrow involvement in a patient with primary hyperoxaluria.Int J Surg Pathol. 2010 Jun;18(3):213. doi: 10.1177/1066896909356570. Epub 2009 Dec 24. Int J Surg Pathol. 2010. PMID: 20034985 No abstract available.
-
Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.Clin Transplant. 1997 Oct;11(5 Pt 1):361-5. Clin Transplant. 1997. PMID: 9361924
-
Combined liver-kidney transplantation in primary hyperoxaluria type 1.Eur J Pediatr. 1999 Dec;158 Suppl 2:S75-80. doi: 10.1007/pl00014327. Eur J Pediatr. 1999. PMID: 10603104 Review.
-
Management of oxalosis.Kidney Int Suppl. 1996 Jan;53:S93-8. Kidney Int Suppl. 1996. PMID: 8770999 Review.
Cited by
-
Late Diagnosis of Primary Hyperoxaluria in an Adult Patient With End-Stage Renal Disease and Bicytopenia.Cureus. 2023 Jul 26;15(7):e42469. doi: 10.7759/cureus.42469. eCollection 2023 Jul. Cureus. 2023. PMID: 37637636 Free PMC article.
-
Primary Hyperoxaluria Diagnosed Based on Bone Marrow Biopsy in Pancytopenic Adult with End Stage Renal Disease.Case Rep Hematol. 2015;2015:402947. doi: 10.1155/2015/402947. Epub 2015 Nov 8. Case Rep Hematol. 2015. PMID: 26634160 Free PMC article.
-
Pancytopenia as a Complication of Primary Hyperoxaluria.Indian J Nephrol. 2019 May-Jun;29(3):214-215. doi: 10.4103/ijn.IJN_204_18. Indian J Nephrol. 2019. PMID: 31142973 Free PMC article. No abstract available.
-
Bone Marrow Oxalosis in a Patient With Pancytopenia Following Bilateral Nephrectomy.Ann Lab Med. 2016 May;36(3):266-7. doi: 10.3343/alm.2016.36.3.266. Ann Lab Med. 2016. PMID: 26915618 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical